Quantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution

Nat Biotechnol. 2023 Mar;41(3):344-354. doi: 10.1038/s41587-022-01505-w. Epub 2022 Oct 27.

Abstract

Functional characterization of pseudouridine (Ψ) in mammalian mRNA has been hampered by the lack of a quantitative method that maps Ψ in the whole transcriptome. We report bisulfite-induced deletion sequencing (BID-seq), which uses a bisulfite-mediated reaction to convert pseudouridine stoichiometrically into deletion upon reverse transcription without cytosine deamination. BID-seq enables detection of abundant Ψ sites with stoichiometry information in several human cell lines and 12 different mouse tissues using 10-20 ng input RNA. We uncover consensus sequences for Ψ in mammalian mRNA and assign different 'writer' proteins to individual Ψ deposition. Our results reveal a transcript stabilization role of Ψ sites installed by TRUB1 in human cancer cells. We also detect the presence of Ψ within stop codons of mammalian mRNA and confirm the role of Ψ in promoting stop codon readthrough in vivo. BID-seq will enable future investigations of the roles of Ψ in diverse biological processes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Base Composition
  • Humans
  • Mammals / genetics
  • Mice
  • Pseudouridine* / genetics
  • Pseudouridine* / metabolism
  • RNA / genetics
  • RNA / metabolism
  • RNA Processing, Post-Transcriptional* / genetics
  • RNA Processing, Post-Transcriptional* / physiology
  • RNA, Messenger* / genetics
  • RNA, Messenger* / metabolism
  • Sequence Analysis, RNA
  • Sulfites

Substances

  • hydrogen sulfite
  • Pseudouridine
  • pseudouridine synthases
  • RNA
  • RNA, Messenger
  • Sulfites